Health
New drug targeting DNA repair shows promise in range of advanced cancers – Science Codex
A new precision drug which stops cancer from repairing its DNA has shown promise in an early-stage clinical trial – highlighting the potential of a new class of drugs known as ATR inhibitors.
The drug candidate, tested in humans for the first time, was shown to be well tolerated and stopped the growth of tumours in over half of patients treated.
People in the trial had a range of advanced, heavily pre-treated cancers including breast, bowel and prostate tumours. It is remarkable to see the ne…
-
General21 hours agoHome of Andrii Yermak, Zelenskyy’s chief of staff, raided by anti-corruption unit
-
General10 hours agoProtecting victims of explicit AI content online
-
Business13 hours agoIs this the best ASX ETF to diversify your portfolio with?
-
General22 hours agoEight arrested and 128 people dead as alarm faults confirmed in Hong Kong fire